Cynomolgus TNF-alpha / TNFA Protein
TNF, TNFA, TNFSF2
- 100ug (NPP1712) Please inquiry
| Catalog Number | P90330-CNAE |
|---|---|
| Organism Species | Cynomolgus |
| Host | E. coli |
| Synonyms | TNF, TNFA, TNFSF2 |
| Molecular Weight | The recombinant cynomolgus TNF consists of 158 amino acids and has a calculated molecular mass of 17.4 kDa. |
| predicted N | Met |
| SDS-PAGE |  |
| Purity | > 95 % as determined by SDS-PAGE. |
| Protein Construction | A DNA sequence encoding the cynomolgus TNF (NP_001272206.1) (Val 77-Leu233) was expressed and purified with an initial Met. |
| Bio-activity | Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. The ED50 for this effect is typically 1-5 ng/ml. |
| Research Area | Cancer |Oncoprotein & suppressor & biomarker |Oncoprotein |Growth Factor & Receptor |Tumor Necrosis Factor (TNF) & Receptor |Tumor Necrosis Factor (TNF) | |
| Formulation | Lyophilized from sterile PBS, pH 7.4. 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
| Background | Tumor necrosis factor alpha (TNF-alpha), also known as TNF, TNFA or TNFSF2, is the prototypic cytokine of the TNF superfamily, and is a multifunctional molecule involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. Two receptors, TNF-R1 (TNF receptor type 1; CD120a; p55/60) and TNF-R2 (TNF receptor type 2; CD120b; p75/80), bind to TNF-alpha. TNF-alpha protein is produced mainly by macrophages, and large amounts of this cytokine are released in response to lipopolysaccharide, other bacterial products, and Interleukin-1 (IL-1). TNF-alpha is involved in fighting against the tumorigenesis, thus, is regarded as a molecular insight in cancer treatment. |
| Reference |